Robbins Farley’s Phibro Animal Health PAHC Stock Holding History

Robbins Farley’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-98	Closed	-$2.5K	–	188
2025 Q2	$2.5K	Buy	+98	New	+$2.14K	﹤0.01%	135

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Robbins Farley's PAHC Position: Q3 2025 in Review

Robbins Farley sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 98 shares — an estimated $2.5K sold.

Robbins Farley first reported a position in PAHC in Q2 2025 and held it in 1 quarter. The position peaked at $2.5K in Q2 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

Robbins Farley reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
Robbins Farley sold 98 Phibro Animal Health shares in Q3 2025, an estimated $2.5K.
Robbins Farley first reported a position in Phibro Animal Health in Q2 2025 and held it in 1 quarter.
Robbins Farley's Phibro Animal Health position peaked at $2.5K in Q2 2025.
218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Robbins Farley's 13F filing for Q3 2025, filed 15 Oct 2025.